Table 2.
Factors of Severity | Genes and Function |
---|---|
Decreased Immune Response |
HLA-A, -B, -C—immune regulatory genes NCAM1—decreased immune cell expansion and interferon signaling |
Factors that Correlate with Severity |
APOB—decreased apolipoproteins COVID-19 patient plasma B2M—decreased organ expression contributes to renal and cardiovascular damage |
Fibrosis | ACTA1—pro-fibrotic factor |
Increased Hypercytokinemia |
ALCAM—increased cytokine production FHL1—increased cytokine translation |
Increased Viral Transcription and Translation |
CA12—translational control SYNE2—contributes to cell cycle regulation |
Multi-Organ Failure | PCDH9—cadherin disruption decreases endothelial barrier integrity |
Organ Specific Damage |
HSPA1A—ischemia and kidney damage PDE3B—induces angiogenesis, contributes to ARDS SGCD—related to cardiomyopathy SLC39A14—related to ferroptosis in liver |